中國宏光(08646.HK)擬向控股股東配發9900萬股 淨籌約3925萬港元
格隆匯5月17日丨中國宏光(08646.HK)公佈,於2022年5月17日,公司與明亮環球(持有公司已發行股本約50.25%)訂立了股份認購協議,據此,公司有條件同意配發及發行,且明亮環球有條件同意根據股份認購協議的條款認購9900萬股認購股份,佔經擴大後公司股份約24.81%。每股認購價為0.4港元,較5月17日收市價0.46港元折讓約13.04%。
股份認購事項所得款項總額合計將約為3960萬港元。股份認購事項所得款項淨額總額將約為3925萬港元。公司擬將股份認購事項所得款項淨額的(a)60%用於維持及經營現有業務(包括購買原材料、升級及購買生產設備以提高效率及質量以及償還借款);(b)30%用於潛在收購事項及發展新業務;及(c)10%用作集團一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.